Leading science, pioneering therapies

CRM Publications

Found 11 results
Filters: Keyword is Neoplastic Stem Cells  [Clear All Filters]
2014
Sarvi S, Mackinnon AC, Avlonitis N, Bradley M, Rintoul RC, Rassl DM, Wang W, Forbes SJ, Gregory CD, Sethi T.  2014.  CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.Cancer Res. 74(5):1554-65.
Gangoso E, Thirant C, Chneiweiss H, Medina JM, Tabernero A.  2014.  A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype.Cell Death Dis. 5:e1023.
2013
Diffner E, Beck D, Gudgin E, Thoms JAI, Knezevic K, Pridans C, Foster S, Goode D, Lim WKhong, Boelen L et al..  2013.  Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.Blood. 121(12):2289-300.
Ding Y, Hubert CG, Herman J, Corrin P, Toledo CM, Skutt-Kakaria K, Vazquez J, Basom R, Zhang B, Risler JK et al..  2013.  Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.Cancer Discov. 3(2):198-211.
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.Genes Dev. 27(9):1032-45.
Carén H, Pollard SM, Beck S.  2013.  The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.Mol Aspects Med. 34(4):849-62.
Porlan E, Morante-Redolat JManuel, M Marqués-Torrejón Á, Andreu-Agulló C, Carneiro C, Gómez-Ibarlucea E, Soto A, Vidal A, Ferrón SR, Fariñas I.  2013.  Transcriptional repression of Bmp2 by p21(Waf1/Cip1) links quiescence to neural stem cell maintenance.Nat Neurosci. 16(11):1567-75.
2012
Danovi D, Folarin AA, Baranowski B, Pollard SM.  2012.  High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.Methods Enzymol. 506:311-29.
2010
Danovi D, Falk A, Humphreys P, Vickers R, Tinsley J, Smith AG, Pollard SM.  2010.  Imaging-based chemical screens using normal and glioma-derived neural stem cells.Biochem Soc Trans. 38(4):1067-71.
2009
Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M et al..  2009.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.Cell Stem Cell. 4(6):568-80.
2004
Chambers I, Smith A.  2004.  Self-renewal of teratocarcinoma and embryonic stem cells.Oncogene. 23(43):7150-60.